Jinxin Fertility Group Limited (HKG:1951)

Market Cap	6.06B -21.5%
Revenue (ttm)	2.95B -5.8%
Net Income	-1.09B
EPS	-0.40
Shares Out	2.67B
PE Ratio	n/a
Forward PE	21.32
Dividend	0.04 (1.89%)
Ex-Dividend Date	Jun 29, 2026

Volume	13,031,500
Open	2.270
Previous Close	2.270
Day's Range	2.240 - 2.290
52-Week Range	2.090 - 3.700
Beta	0.78
Analysts	Buy
Price Target	3.18 (+40.09%)
Earnings Date	Mar 26, 2026

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and internationally. The company provides two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also related services, such as nutrition guidance, Chinese medicine treatment, and psychological cou...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,494
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

Financial numbers in CNY

Analyst Summary

According to 12 analysts, the average rating for 1951 stock is "Buy." The 12-month stock price target is $3.18, which is an increase of 40.09% from the latest price.

Price Target

$3.18

(40.09% upside)

Analyst Consensus: Buy